196 related articles for article (PubMed ID: 28742995)
41. Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts.
Weng J; Tu M; Wang P; Zhou X; Wang C; Wan X; Zhou Z; Wang L; Zheng X; Li J; Wang Z; Wang Z; Chen C
Biomed Pharmacother; 2019 Jul; 115():108889. PubMed ID: 31071512
[TBL] [Abstract][Full Text] [Related]
42. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
43. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
44. Possible involvement of p38 MAP kinase in prostaglandin E1-induced ALP activity in osteoblast-like cells.
Kakita A; Suzuki A; Ono Y; Miura Y; Itoh M; Oiso Y
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):469-74. PubMed ID: 15062850
[TBL] [Abstract][Full Text] [Related]
45. Chrysin promotes osteogenic differentiation via ERK/MAPK activation.
Zeng W; Yan Y; Zhang F; Zhang C; Liang W
Protein Cell; 2013 Jul; 4(7):539-47. PubMed ID: 23744338
[TBL] [Abstract][Full Text] [Related]
46. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation.
Hu Y; Chan E; Wang SX; Li B
Endocrinology; 2003 May; 144(5):2068-74. PubMed ID: 12697715
[TBL] [Abstract][Full Text] [Related]
47. Study of the osteogenesis effect of icariside II and icaritin on canine bone marrow mesenchymal stem cells.
Luo G; Xu B; Wang W; Wu Y; Li M
J Bone Miner Metab; 2018 Nov; 36(6):668-678. PubMed ID: 29264750
[TBL] [Abstract][Full Text] [Related]
48. The role of p38 MAP kinase and c-Jun N-terminal protein kinase signaling in the differentiation and apoptosis of immortalized neural stem cells.
Yang SR; Cho SD; Ahn NS; Jung JW; Park JS; Jo EH; Hwang JW; Kim SH; Lee BH; Kang KS; Lee YS
Mutat Res; 2005 Nov; 579(1-2):47-57. PubMed ID: 16046226
[TBL] [Abstract][Full Text] [Related]
49. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation.
Dai Z; Li Y; Quarles LD; Song T; Pan W; Zhou H; Xiao Z
Phytomedicine; 2007 Dec; 14(12):806-14. PubMed ID: 17689939
[TBL] [Abstract][Full Text] [Related]
50. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
51. Growth/differentiation factor-5 induces osteogenic differentiation of human ligamentum flavum cells through activation of ERK1/2 and p38 MAPK.
Zhong ZM; Chen JT; Zhang Y; Zha DS; Lin ZS; Zhao CY; Xu JC; Li T; Xu ZX
Cell Physiol Biochem; 2010; 26(2):179-86. PubMed ID: 20798501
[TBL] [Abstract][Full Text] [Related]
52. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture.
Liao QC; Xiao ZS; Qin YF; Zhou HH
Acta Pharmacol Sin; 2007 Oct; 28(10):1597-602. PubMed ID: 17883946
[TBL] [Abstract][Full Text] [Related]
53. Oral malodorous compound inhibits osteoblast proliferation.
Imai T; Ii H; Yaegaki K; Murata T; Sato T; Kamoda T
J Periodontol; 2009 Dec; 80(12):2028-34. PubMed ID: 19961386
[TBL] [Abstract][Full Text] [Related]
54. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
55. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A
Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771
[TBL] [Abstract][Full Text] [Related]
56. Induction of the matrix metalloproteinase-2 activation system in arteries by tensile stress. Involvement of the p38 MAP-kinase pathway.
Grabellus F; Worm K; Schmid KW
Pathol Res Pract; 2007; 203(3):135-43. PubMed ID: 17306932
[TBL] [Abstract][Full Text] [Related]
57. p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes.
Lee SK; Jang HJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
Life Sci; 2006 Sep; 79(15):1419-27. PubMed ID: 16697418
[TBL] [Abstract][Full Text] [Related]
58. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
Kozawa O; Hatakeyama D; Uematsu T
J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
[TBL] [Abstract][Full Text] [Related]
59. p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells.
Ko J; Yun CY; Lee JS; Kim JH; Kim IS
Exp Mol Med; 2007 Apr; 39(2):129-38. PubMed ID: 17464174
[TBL] [Abstract][Full Text] [Related]
60. Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway.
Yu J; Eto M; Kozaki K; Akishita M; Okabe T; Ouchi Y
Eur J Pharmacol; 2008 Jul; 589(1-3):32-6. PubMed ID: 18541231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
